ArticleJTO clinical and research reports2025

Evaluation of the Safety, Pharmacokinetics, and Antitumor Activity of Tusamitamab Ravtansine in Patients With Nonsquamous NSCLC With High or Moderate Expression of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5.

Anas Gazzah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.